The Influence of LMA Cuff Pressure on Gastric Insufflation Assessed by Ultrasound in Pediatric Patient

July 31, 2020 updated by: Jin-Tae Kim, Seoul National University Hospital

The Influence of LMA Cuff Pressure on Oropharyngeal Leak Pressure and Gastric Insufflation Assessed by Ultrasound in Pediatric Patients

Cuff inflation up to the maximum cuff pressure when using LMA flexible can cause sore throat and discomfort after the surgery, and if the surgery is unexpectedly prolonged, there can be a side effect that can cause ischemic damage around the neck. If keeping cuff pressure low will not increase gastric insufflation and there is no change in other outcome variables, keeping it low may have a positive effect on anesthesia management and outcome in children.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

230

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 6 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • pediatric patients undergoing general anesthesia with LMA flexible

Exclusion Criteria:

  • Unstable vital sign, significant arrhythmia or hypotension, Shock
  • anticipated difficult intubation or the patient who have facial deformity
  • high risk of aspiration
  • recent upper respiratory tract infection history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: higher pressure
During the operation, cuff pressure of LMA flexible is maintained to 50cmH2O
During the operation, cuff pressure of LMA flexible is maintained to 50cmH2O
EXPERIMENTAL: lower pressure
During the operation, cuff pressure of LMA flexible is maintained to 30cmH2O
During the operation, cuff pressure of LMA flexible is maintained to 30cmH2O

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of gastric insufflation(antrum)
Time Frame: During the surgery(up to 3 hours)
Incidence of gastric insufflation which was recognized in gastric antrum with ultrasound
During the surgery(up to 3 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The size of gastric antrum and body
Time Frame: During the surgery(up to 3 hours)
The size of gastric antrum and body assessed immediately after insertion of LMA flexible and after finishing the surgery
During the surgery(up to 3 hours)
Time for insertion of LMA flexible
Time Frame: During the anesthesia induction(up to 1 hour)
Time for insertion of LMA flexible
During the anesthesia induction(up to 1 hour)
Success rate of insertion of LMA flexible
Time Frame: During the anesthesia induction(up to 1 hour)
Success rate of insertion of LMA flexible
During the anesthesia induction(up to 1 hour)
The number of insertion attempt
Time Frame: During the anesthesia induction(up to 1 hour)
The number of insertion attempt
During the anesthesia induction(up to 1 hour)
The number and the type of additional manipulation for successful ventilation
Time Frame: During the surgery(up to 3 hours)
The number and the type of additional manipulation for successful ventilation
During the surgery(up to 3 hours)
Ease of insertion of LMA flexible
Time Frame: During the anesthesia induction(up to 1 hour)
Ease of insertion of LMA flexible(very easy, easy, moerate, difficult, very difficult)
During the anesthesia induction(up to 1 hour)
Incidence of gastric insufflation(body)
Time Frame: During the surgery(up to 3 hours)
Incidence of gastric insufflation which was recognized in gastric body with ultrasound
During the surgery(up to 3 hours)
Incidence of gastric insufflation recognized with the ausculation
Time Frame: During the surgery(up to 3 hours)
Incidence of gastric insufflation recognized with the ausculation after finishing surgery
During the surgery(up to 3 hours)
peak pressure observed before, during, after surgery
Time Frame: During the surgery(up to 3 hours)
peak pressure observed before, during, after surgery
During the surgery(up to 3 hours)
oropharyngeal leak pressure
Time Frame: During the surgery(up to 3 hours)
oropharyngeal leak pressure will be assessed by setting the APL valve of the circle system at 30 cmH2O with fresh gas flow of 3 L/min after the surgery
During the surgery(up to 3 hours)
the complication rate
Time Frame: During the surgery and after surgery (up to 6 hours)
the complication rate such as desaturation, blood staining of LMA flexible, hoarseness, dental/lip/tongue injury, aspiration
During the surgery and after surgery (up to 6 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

August 10, 2020

Primary Completion (ANTICIPATED)

August 10, 2021

Study Completion (ANTICIPATED)

August 10, 2021

Study Registration Dates

First Submitted

July 28, 2020

First Submitted That Met QC Criteria

July 28, 2020

First Posted (ACTUAL)

July 31, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 4, 2020

Last Update Submitted That Met QC Criteria

July 31, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Gastric insufflation

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aspiration

Clinical Trials on higher pressure

Subscribe